NOTV:NASDAQInotiv, Inc. Analysis
Data as of 2026-08-10 - not real-time
$0.08
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
At $0.0800, Inotiv Inc shows no decisive moving-average alignment, leaving the trend neutral.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Revenue is contracting at 5.4% on a -17.1% profit margin.
Risk scores 6 out of 10, which is elevated for this asset class. With a beta of 3.77, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is sell, conviction 4 out of 10.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Revenue is contracting at 5.4% on a -17.1% profit margin.
Risk scores 6 out of 10, which is elevated for this asset class. With a beta of 3.77, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is sell, conviction 4 out of 10.
Top Market Events
WEST LAFAYETTE, Ind., July 14, 2026--Inotiv, Inc. NASDAQ: NOTV the "Company", or "Inotiv" , a leading Contract Research...WEST LAFAYETTE, Ind., July 20, 2026--Inotiv, Inc. NASDAQ: NOTV the "Company", or "Inotiv" , a leading Contract Research...Marks critical milestone in financial restructuring process, positioning Inotiv to emerge well-capitalized, with an...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Beta of 3.77 versus the benchmark
- Price-to-book of 0.04
- Negative profit margin of -17.1%
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Beta of 3.77 versus the benchmark
- Negative profit margin of -17.1%
- Price-to-book of 0.04
Long Term
> 3 yearsCautious
Model confidence: 4/10
Key Factors
- Negative profit margin of -17.1%
- Negative return on equity of -74.1%
- Revenue contracting at -5.4%
Key Metrics & Analysis
Financial Health
Revenue Growth-5.40%
Profit Margin-17.14%
P/E Ratio-1.6
ROE-74.09%
ROA-4.02%
Debt/Equity632.65
P/B Ratio0.0
Op. Cash Flow$354.0K
Free Cash Flow$23.6M
Industry P/E29.5
Technical Analysis
TrendNeutral
MACDNeutral
VolumeStable
Fear & Greed Index93.8
Valuation
GradeFair
TypeBlend
Risk Assessment
Beta3.77
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.